Non-alcoholic Steatohepatitis
To begin the course, please login or register by clicking ENROLL. After logging in, you will be able to complete the pretest and view the video/documents. You will have the option to complete the posttest, evaluation and receive credit. Some courses may have an associated cost.
Starts On:
7/1/2021: 12:00 AM
Ends On:
5/8/2022: 12:00 AM
Session Type:
Internet Activity Enduring Material
Credits:
0.75
Description:
Marilyn Bornefeld Endowed Chair in Gastrointestinal Research and Treatment
Associate Chairman for Clinical Programs
Disclosures
Financial Relationships:
Speakers Bureau/Honoraria: AbbVie Inc, Intercept, SALIX, Gilead Sciences Inc
Ownership Interest/Stock Equity: AbbVie Inc.
Presenters should indicate if speaking off label. This activity originated as a presentation at the CME activity, Washington University Kilo Diabetes & Midwest Pediatric Endocrine Society Symposium, November 8-9, 2019, which was supported in part by AstraZeneca Pharmaceuticals and Medtronic Diabetes.
Professor of Pediatrics
Director, Type 1 Diabetes Research Team
Division of Endocrinology and Diabetology; Riley Hospital for Children
Department of Pediatrics
Indiana University School of Medicine, Indianapolis, Indiana
Financial Relationships:
Research Support/Grants: Amgen, Caladrius, Janssen, MannKind, Medtronic, Zealand
Other Relationships, in kind support for research project: Dexcom, Inc.
Ana María Arbeláez, MD, MSCI, Associate Professor of Pediatrics, Course Co-Chair
Chief, Division of Pediatric Endocrinology and Diabetes
Financial Relationships: Nothing to disclose
Janet B. McGill, MD, Professor of Medicine, Course Co-Chair
Division of Endocrinology, Metabolism and Lipid Research
Financial Relationships:
Consulting/Advisory Boards: Aegerion, Bayer, Boehringer Ingelheim, Dexcom, Metavant, Novo Nordisk
Speaker's Bureau: Aegerion, Dexcom, Janssen
Research Support/Grants: NIH, Dexcom, Helmsley Trust, Medtronic, Novo Nordisk, Sanofi
Neil Harris White, MD Professor of Pediatrics
Division of Pediatric Endocrinology and Diabetes
Financial Relationships:
Consulting/Advisory Committees: Daiichi Sankyo Pharma Development
Research: Proventions Bio, Inc
Jeffrey Blunt, PharmD, Lead Clinical Pharmacist
Department of Pharmacy, Barnes Jewish Hospital
Financial Relationships: Nothing to disclose
Mary Jane Clifton, BA, CCRP, Senior Clinical Research Coordinator
Division of Endocrinology, Metabolism and Lipid Research
Financial Relationships: Nothing to disclose
Charles Kilo, MD, FACP, FACE, Instructor in Clinical Medicine
Financial Relationships: Nothing to disclose
Carol Recklein, RN, MHS, CDE, Clinical Research Coordinator
Financial Relationships:
Consulting/Advisory Committees: Insulet Corporation, Radius Health, Inc.
Speakers Bureau/Honoraria: Sanofi Aventis
Amy E. Riek, MD, MSCI, Assistant Professor of Medicine
Division of Endocrinology, Metabolism and Lipid Research
Financial Relationships: Nothing to disclose
Faculty
Jeffrey S. Crippin, MD, Professor of MedicineMarilyn Bornefeld Endowed Chair in Gastrointestinal Research and Treatment
Associate Chairman for Clinical Programs
Disclosures
Financial Relationships:
Speakers Bureau/Honoraria: AbbVie Inc, Intercept, SALIX, Gilead Sciences Inc
Ownership Interest/Stock Equity: AbbVie Inc.
Presenters should indicate if speaking off label. This activity originated as a presentation at the CME activity, Washington University Kilo Diabetes & Midwest Pediatric Endocrine Society Symposium, November 8-9, 2019, which was supported in part by AstraZeneca Pharmaceuticals and Medtronic Diabetes.
Planning Committee
Linda A. DiMeglio, MD, MPH, Course Co-ChairProfessor of Pediatrics
Director, Type 1 Diabetes Research Team
Division of Endocrinology and Diabetology; Riley Hospital for Children
Department of Pediatrics
Indiana University School of Medicine, Indianapolis, Indiana
Financial Relationships:
Research Support/Grants: Amgen, Caladrius, Janssen, MannKind, Medtronic, Zealand
Other Relationships, in kind support for research project: Dexcom, Inc.
Ana María Arbeláez, MD, MSCI, Associate Professor of Pediatrics, Course Co-Chair
Chief, Division of Pediatric Endocrinology and Diabetes
Financial Relationships: Nothing to disclose
Janet B. McGill, MD, Professor of Medicine, Course Co-Chair
Division of Endocrinology, Metabolism and Lipid Research
Financial Relationships:
Consulting/Advisory Boards: Aegerion, Bayer, Boehringer Ingelheim, Dexcom, Metavant, Novo Nordisk
Speaker's Bureau: Aegerion, Dexcom, Janssen
Research Support/Grants: NIH, Dexcom, Helmsley Trust, Medtronic, Novo Nordisk, Sanofi
Neil Harris White, MD Professor of Pediatrics
Division of Pediatric Endocrinology and Diabetes
Financial Relationships:
Consulting/Advisory Committees: Daiichi Sankyo Pharma Development
Research: Proventions Bio, Inc
Jeffrey Blunt, PharmD, Lead Clinical Pharmacist
Department of Pharmacy, Barnes Jewish Hospital
Financial Relationships: Nothing to disclose
Mary Jane Clifton, BA, CCRP, Senior Clinical Research Coordinator
Division of Endocrinology, Metabolism and Lipid Research
Financial Relationships: Nothing to disclose
Charles Kilo, MD, FACP, FACE, Instructor in Clinical Medicine
Financial Relationships: Nothing to disclose
Carol Recklein, RN, MHS, CDE, Clinical Research Coordinator
Financial Relationships:
Consulting/Advisory Committees: Insulet Corporation, Radius Health, Inc.
Speakers Bureau/Honoraria: Sanofi Aventis
Amy E. Riek, MD, MSCI, Assistant Professor of Medicine
Division of Endocrinology, Metabolism and Lipid Research
Financial Relationships: Nothing to disclose
Objectives:
The intended result of this activity is increased knowledge/competence, and upon completion of this course, participants should be able to:
- Discuss the risk factors for non-alcoholic fatty liver disease.
- Discuss genetic factors affecting non-alcoholic fatty liver disease.
- Discuss present and potential future treatments of non-alcoholic fatty liver disease.
Additional Information:
Target Audience:This course is designed for pediatric and adult endocrinologists, internalists, family and general practice practitioners, hospitalists, physician assistants, nurses, nurse practitioners, certified diabetic educators, pharmacists and other health care professionals who care for patients with diabetes and endocrine disorders.
Publication Date: July 1, 2021
Expiration Date: May 8, 2022
Target Audience:This course is designed for pediatric and adult endocrinologists, internalists, family and general practice practitioners, hospitalists, physician assistants, nurses, nurse practitioners, certified diabetic educators, pharmacists and other health care professionals who care for patients with diabetes and endocrine disorders.
Publication Date: July 1, 2021
Expiration Date: May 8, 2022
Accreditation Information:
In support of improving patient care, this activity has been planned and implemented by Washington University School of Medicine in St. Louis and Midwest Pediatric Endocrine Society. Washington University School of Medicine in St. Louis is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Awarded for this Activity:
In support of improving patient care, this activity has been planned and implemented by Washington University School of Medicine in St. Louis and Midwest Pediatric Endocrine Society. Washington University School of Medicine in St. Louis is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Awarded for this Activity:
Credit Statement:
American Medical Association (AMA Credit)
Washington University School of Medicine in St. Louis designates this enduring material for a maximum of .75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Nurses Credentialing Center (ANCC Credit)
Washington University School of Medicine in St. Louis designates this enduring material for a maximum of .75 ANCC contact hour.
American Medical Association (AMA Credit)
Washington University School of Medicine in St. Louis designates this enduring material for a maximum of .75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Nurses Credentialing Center (ANCC Credit)
Washington University School of Medicine in St. Louis designates this enduring material for a maximum of .75 ANCC contact hour.
References:
- Chalasani. Hepatology. 2018;67:328.
- Romeo S, et al. Nat Genet 2008; 40:1461
- Stender S, et al. Nat Genet 2017; 49:842
- Chalasani. Hepatology. 2018;67:328.
- EASL, EASD, EASO. J Hepatol. 2016;64:1388.
Disclosure Information:
It is the policy of Washington University School of Medicine in St. Louis, Continuing Medical Education, to ensure balance, independence, objectivity and scientific rigor in all its educational activities. All planners, faculty and other persons who may influence content of this CME activity have disclosed all relevant financial relationships with commercial interests. All disclosures have been reported and are indicated with their presentations. Any potential conflicts were addressed and resolved.
Presenters are also expected to openly disclose inclusion of discussion of any off-label, experimental, or investigational use of drugs or devices in their presentations.
Presentations are expected to be based on evidence that is accepted within the profession of medicine as adequate justification for their indication in the care of patients. All scientific research should conform to the generally accepted standards of experimental design, data collection and analysis. These presentations are not an endorsement of any commercial interests.
These presentations are the views and experiences of the presenters. The presenters' views do not represent the policy or position of Washington University School of Medicine in St. Louis. Washington University School of Medicine in St. Louis, Continuing Medical Education, is the provider for CME credits.
Presenters are also expected to openly disclose inclusion of discussion of any off-label, experimental, or investigational use of drugs or devices in their presentations.
Presentations are expected to be based on evidence that is accepted within the profession of medicine as adequate justification for their indication in the care of patients. All scientific research should conform to the generally accepted standards of experimental design, data collection and analysis. These presentations are not an endorsement of any commercial interests.
These presentations are the views and experiences of the presenters. The presenters' views do not represent the policy or position of Washington University School of Medicine in St. Louis. Washington University School of Medicine in St. Louis, Continuing Medical Education, is the provider for CME credits.
